NewNow you can hear Fox News article!
There is no indication of the disease after taking an experimental medicine to a person with the deadliest form of brain cancer.
Ben Trotman was 40 years old when he was diagnosed with the most aggressive cancer brain tumor with glioblastoma in 2022. Patients usually live on an average 15 months after the diagnosis, and the five -year survival rate is just 6.9%.
Trotman was sent to the National Hospital for Neurology and Neurosurgery at University College London Hospitals (UCLH), where he was advisable UCLH Medical Oncologist Dr. A press release was considered detailed in a press release by Paul Mulholland.
Ancient ‘Pharaoh’s curse’ shows promise in killing fungus cancer cells
As the sole person enrolled in a test that eventually stopped due to lack of patients, Trotman found a drug called a target immunotherapy treatment ipilumum.
The ipilimumab is an antibody that binds a protein on immune cells (T cells) to press the immune system to press the cancer cells, so that it can attack and kill cancer according to the National Cancer Institute, according to the National Cancer Institute.
The Ben Trotman, depicted with his wife Emily and daughter Mabel, was 40, when she was diagnosed with glioblastoma, the most aggressive cancer brain tumor in 2022. (Mary Mangan through University College London)
Trotman also received radiation and chemotherapy. More than two years later, their quarterly scans show no signs of cancer.
His oncologist, Mulholland said, “It is very unusual to have a clear scan with glioblastoma, especially when he did not have follow -up surgery, which was planned to remove all the tumors that appear on the scan.”
“We felt that we had a lucky break in an otherwise disastrous situation.”
“We hope that Immunotherapy and follow-up treatment Ben has caught his tumor in the Gulf-and it is still, which we are happy to see.”
Two months after receiving the IPLMUMAB, Trotman married his wife, Emily. In April 2025, he welcomed his daughter, Mabel.
Two months after receiving the IPLMUMAB, Trotman married his wife, Emily. In April 2025, he welcomed his daughter, Mabel. (Through Ben and Emily Trotman University College London)
Emily Trotman said, “To get this diagnosis was the most painful experience – we were struggling with the fact that Ben Zahi was apparently to stay for months from being completely healthy.”
Click here to get Fox News app
“If we did not meet Dr. Mulholland, it would have been for us. We realized that we had a lucky break in a disastrous situation.”
Ben Trotman said, “We do not know clearly what the future is, but the immunotherapy was treated and these encouraging scan have been given to get results [us] Hope a little. ,
Dr. Paul Mulholand (left) is depicted with Dame Cybin McDonagh (right), who raised funds to support a new test for experimental glioblastoma drug. (Mary Mangan through University College London)
“We are focusing on the reconstruction of life that we thought we were lost and enjoying being a parents.”
Mulholland and his team have now opened another clinical test for patients who have been diagnosed with glioblastoma.
Click here to sign up for our health newspaper
Sixteen patients will be admitted for testing, which is sponsored by UCL. According to the press release, treatment will be administered at the National Hospital for NIHR UCLH’s clinical research facility and neurology and neurosurgery.
Patients will receive iPilumumab before proceeding to standard treatments that may include surgery, radiotherapy, and chemotherapy.
Glioblastoma patients usually live on an average 15 months after diagnosis, and the five -year survival rate is just 6.9%. (Istock)
“The important element of this test is that patients will promote their immune system by the drug, before they do any other treatment, when they fit and are enough to bear immunotherapy,” Mulholland said in the release.
The Win-Glio Trial-The name is “Margaret Trial”-Co-Co. Dame Ceoban McDonagh, has been funded by the efforts of the sister of Margaret McDonagh, a woman from London who died of glioblastoma in 2023 and was treated by Mulholland.
For more health articles, travel www.foxnews.com/health
Ben said that he is “happy” that the new test is proceeding with the same immunotherapy medicine he received.
“It will give people some hope to some hope with gliooblastoma.”
